159 results on '"P. Imbert"'
Search Results
2. Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector
3. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells
4. Physical interaction of the bHLH LYL1 protein and NF-κB1 p105
5. Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules
6. Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.
7. Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells.
8. IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes
9. The influence of endothelial metabolic reprogramming on the tumor microenvironment
10. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
11. Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10
12. ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3
13. IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression
14. Elevated EDAR signalling promotes mammary gland tumourigenesis with squamous metaplasia
15. PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs
16. PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
17. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
18. Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma
19. EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis
20. Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling
21. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
22. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest
23. Thymine DNA glycosylase as a novel target for melanoma
24. Pathways from senescence to melanoma: focus on MITF sumoylation
25. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma
26. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
27. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
28. Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium
29. Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors
30. Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors
31. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway
32. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening
33. The origin of breast tumor heterogeneity
34. Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
35. Differential effects of AMPK agonists on cell growth and metabolism
36. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway
37. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma
38. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity
39. Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies
40. Complex cellular functions of the von Hippel–Lindau tumor suppressor gene: insights from model organisms
41. Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization
42. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases
43. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
44. NF-κB addiction and its role in cancer: ‘one size does not fit all’
45. RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma
46. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells
47. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5
48. VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo
49. NF-κB signaling, liver disease and hepatoprotective agents
50. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-κB and ATF4
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.